1,169
Views
9
CrossRef citations to date
0
Altmetric
MIATA Compliant Research Paper

PEG-rIL-10 treatment decreases FoxP3+ Tregs despite upregulation of intratumoral IDO

, , , , , , & show all
Article: e1197458 | Received 12 Feb 2016, Accepted 29 May 2016, Published online: 15 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Guoying Ni, Lu Zhang, Xiaodan Yang, Hejie Li, Bowei Ma, Shelley Walton, Xiaolian Wu, Jianwei Yuan, Tianfang Wang & Xiaosong Liu. (2020) Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task. Human Vaccines & Immunotherapeutics 16:10, pages 2328-2332.
Read now
Tao Gu, Magdia De Jesus, Heather C. Gallagher, Thomas P. Burris & Nejat K. Egilmez. (2017) Oral IL-10 suppresses colon carcinogenesis via elimination of pathogenicCD4+ T-cells and induction of antitumor CD8+ T-cell activity. OncoImmunology 6:6.
Read now

Articles from other publishers (7)

Kevin M Sullivan, Xiuyun Jiang, Prajna Guha, Christopher Lausted, Jason A Carter, Cynthia Hsu, Kevin P Labadie, Karan Kohli, Heidi L Kenerson, Sara K Daniel, Xiaowei Yan, Changting Meng, Arezou Abbasi, Marina Chan, Y David Seo, James O Park, Ian Nicholas Crispe, Raymond S Yeung, Teresa S Kim, Taranjit S Gujral, Qiang Tian, Steven C Katz & Venu G Pillarisetty. (2023) Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut 72:2, pages 325-337.
Crossref
Yan Tie, Fan Tang, Yu-quan Wei & Xia-wei Wei. (2022) Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. Journal of Hematology & Oncology 15:1.
Crossref
Yanchun Ma, Vera Bauer, Tanja Riedel, Fatima Ahmetlić, Nadine Hömberg, Thomas P. Hofer, Martin Röcken & Ralph Mocikat. (2021) Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapy. Cancer Letters 503, pages 110-116.
Crossref
Martina Damo & Nikhil S. Joshi. (2019) Treg cell IL-10 and IL-35 exhaust CD8+ T cells in tumors. Nature Immunology 20:6, pages 674-675.
Crossref
Fereshteh Mehdipour, Mahboobeh Razmkhah, Zahra Faghih, Mandana Bagheri, Abdol-Rasoul Talei & Abbas Ghaderi. (2019) The significance of cytokine-producing B cells in breast tumor-draining lymph nodes. Cellular Oncology 42:3, pages 381-395.
Crossref
Laura M. Snell, Tracy L. McGaha & David G. Brooks. (2017) Type I Interferon in Chronic Virus Infection and Cancer. Trends in Immunology 38:8, pages 542-557.
Crossref
Yul Ri Chung, Hyun Jeong Kim, Min Hye Jang & So Yeon Park. (2016) Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status. Breast Cancer Research and Treatment 161:3, pages 409-420.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.